Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$3.23 – $4.14
100% from low
Borrow rate
10.96%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.66B | $4.56B | $848.9M | $746.6M | $12.7M | $1.37B | $2.00B | $2.27B |
| Cost of revenue | $5.40B | $4.36B | $774.8M | $698.2M | $337.7M | $1.33B | $1.78B | $2.08B |
| Gross profit | $259.7M | $203.5M | $74.1M | $48.4M | $7.9M | $43.6M | $218.7M | $196.1M |
| Gross margin | 4.6% | 4.5% | 8.7% | 6.5% | 62.1% | 3.2% | 10.9% | 8.6% |
| R&D | $3.1M | $17.6M | $14.8M | $13.3M | $10.2M | $6.4M | $4.1M | $8.2M |
| Operating income | −$1.01B | −$978.0M | −$394.0M | −$387.8M | −$269.8M | −$318.2M | −$139.7M | −$78.4M |
| EBITDA | −$321.7M | −$111.0M | −$635.2M | $785.6M | −$469.1M | −$43.5M | $16.9M | $35.1M |
| Net income | −$1.22B | −$1.08B | −$2.43B | −$400.8M | −$1.44B | $4.22B | $769.6M | $156.0M |
| Net margin | -21.6% | -23.6% | -286.6% | -53.7% | -11352.9% | 307.5% | 38.5% | 6.9% |
| EPS (diluted) | -950.00 | -800.00 | -1450.00 | -225.00 | -800.00 | 2350.00 | 430.00 | 28.00 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds GBCMY.
No tracked institution reports a position in GBCMY as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-06-26 | 1-for-10reverse |
No one on the platform has traded GBCMY yet.
| +0.00% |
| $30M |
| — |
| KPTSFKP Tissue Inc. | $9.60 | +0.00% | $96M | — |
| NWINFNaked Wines plc | $0.94 | +0.00% | $63M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.